We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes CBD products via e-commerce, direct sales, retail and wholesale distribution worldwide. Medical Marijuana Inc. is the first publicly held company vested in the cannabis and industrial hemp space in America. We have brought about... Medical Marijuana, Inc. (OTCMarkets: MJNA) manufactures and distributes CBD products via e-commerce, direct sales, retail and wholesale distribution worldwide. Medical Marijuana Inc. is the first publicly held company vested in the cannabis and industrial hemp space in America. We have brought about many industry firsts, including establishing in 2012 the world's first supply chain of industrial hemp-derived cannabidiol (CBD) consumer products. Subsequently, we were awarded the first distribution rights for these products into the countries of Brazil (April 2014) and Mexico (February 2016). In the U.S., we developed and marketed the first fully THC-free version of CBD products. Thereafter, the World Anti-Doping Agency approved CBD for professional sport and Olympic competition. We maintain our leadership through our international expansion efforts where today we now ship to over 40 countries worldwide making branded products available through e-commerce, direct sales, retail and wholesale distribution channels. Medical Marijuana, Inc. was the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and in many countries has been directly responsible for changing laws and regulations to allow hemp-based CBD consumer products to be marketed. In November 2017, our HempMeds CEO Raul Elizalde addressed the World Health Organization at its hearings on CBD with favorable outcomes for the CBD movement. Show more
March 25, 2022 -- InvestorsHub NewsWire -- via pennymillions -- By: Jessica Kuruthukulangara, SA News Editor Alternet Systems (OTCPK:ALYI) has made initial inroads...
November 5, 2021 -- InvestorsHub NewsWire -- via pennymillions -- AmericanBulls Pharmagreen Biotech, Inc. (PHBI) is reported today by AmericnaBulls (americanbulls.com/PHBI) to be...
When most think of Hong Kong, they likely think of it being a busy place with millions of people with massive corporations, almost like a New York City on the other side of the world. Most...
SAN DIEGO, CA -- August 10, 2021 -- InvestorsHub NewsWire --Â Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched...
November 30, 2020 -- InvestorsHub NewsWire -- via pennymillions -- Forbes reported today that “The Marijuana Opportunity Reinvestment and Expungement (MORE...
Epazz, Inc. (OTC Pink: EPAZ) and Zoom (NASDAQ: ZM) for a Covid-19 Surge Miami, FL -- InvestorsHub NewsWire -- November 9, 2020 -- EmergingGrowth.com, a...
PURA Pop Potential From Under $0.03 To $0.15 After Gap Open To $0.04 March 3, 2020 -- InvestorsHub NewsWire -- via NextBigTicker Puration, Inc. (USOTC:PURA) gapped...
New York, NY -- February 25, 2020 -- via NextBigTicker.com Puration, Inc. (USOTC:PURA) opened up today from yesterday’s close as the PPS continues to show signs that it could...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0006 | 0.0008 | 0.0005 | 16250876 | 0.00068258 | CS |
4 | -0.0004 | -40 | 0.001 | 0.001 | 0.0005 | 21189091 | 0.00077382 | CS |
12 | -0.0005 | -45.4545454545 | 0.0011 | 0.0012 | 0.0005 | 14055939 | 0.00090006 | CS |
26 | -0.0016 | -72.7272727273 | 0.0022 | 0.0024 | 0.0005 | 11486193 | 0.00119963 | CS |
52 | -0.0044 | -88 | 0.005 | 0.0061 | 0.0001 | 12667678 | 0.00204405 | CS |
156 | -0.0236 | -97.520661157 | 0.0242 | 0.03 | 0.0001 | 8631592 | 0.00735858 | CS |
260 | -0.0244 | -97.6 | 0.025 | 0.222 | 0.0001 | 12524861 | 0.02937629 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions